If the Philippine government has “Build, Build, Build” for its economic development program, Uni-Pharma Phils., Inc. has its diversification version of it in “Expand, Expand, Expand”. Amidst the pandemic outbreak in 2020, UPPI decides to enlarge its presence in the Visayas and Mindanao regions by hiring an additional salesforce to take care of promotions and availability, specifically in Cebu/Central Visayas, Iloilo/Bacolod, Cagayan De Oro/Northern Mindanao, and Davao/Southern Mindanao. Similarly in Q2 of 2021, presented with parallel needs in other major parts of the country, UPPI likewise opens North/Central Luzon for operations.
Reaching out to our valued healthcare providers (HCPs) in these key cities was imminent given the continuing need to provide premium and affordable medications, especially in the critical care arena, which plays a vital role in this global health crisis. Uni-Pharma is one with our HCPs’ quest to provide quality and reasonably priced health care that ultimately contributes to positive patient outcomes.
As an emerging National Company in Critical Health Care, UPPI’s diversification goal encompasses both geographic and concentric. While the Company is in its infancy stage of exploring other equally relevant health care products to fully utilize its prevailing marketing and distribution systems, the future seems bright as it continues to stay true to its Mission to help heal the sick and alleviate their pain.